BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

215 related articles for article (PubMed ID: 19485737)

  • 1. Cerebrospinal fluid shunt operations without cranial bandaging. Clinical article.
    Winston KR; Trinidad E; Wilkinson CC; McBride LA
    J Neurosurg Pediatr; 2009 Jun; 3(6):511-5. PubMed ID: 19485737
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Bandages, dressings, and cranial neurosurgery.
    Winston KR; McBride LA; Dudekula A
    J Neurosurg; 2007 Jun; 106(6 Suppl):450-4. PubMed ID: 17566401
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Antimicrobial suture wound closure for cerebrospinal fluid shunt surgery: a prospective, double-blinded, randomized controlled trial.
    Rozzelle CJ; Leonardo J; Li V
    J Neurosurg Pediatr; 2008 Aug; 2(2):111-7. PubMed ID: 18671615
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Do antibiotic-impregnated shunts in hydrocephalus therapy reduce the risk of infection? An observational study in 258 patients.
    Ritz R; Roser F; Morgalla M; Dietz K; Tatagiba M; Will BE
    BMC Infect Dis; 2007 May; 7():38. PubMed ID: 17488498
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Postoperative cerebrospinal fluid wound leakage as a predictor of shunt infection: a prospective analysis of 205 cases. Clinical article.
    Jeelani NU; Kulkarni AV; Desilva P; Thompson DN; Hayward RD
    J Neurosurg Pediatr; 2009 Aug; 4(2):166-9. PubMed ID: 19645552
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Reduction in shunt infection using antibiotic impregnated CSF shunt catheters: an Australian prospective study.
    Pattavilakom A; Xenos C; Bradfield O; Danks RA
    J Clin Neurosci; 2007 Jun; 14(6):526-31. PubMed ID: 17430776
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Clinical and economic consequences of antibiotic-impregnated cerebrospinal fluid shunt catheters.
    Eymann R; Chehab S; Strowitzki M; Steudel WI; Kiefer M
    J Neurosurg Pediatr; 2008 Jun; 1(6):444-50. PubMed ID: 18518694
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Antibiotic prophylaxis for cerebrospinal fluid shunts: a metanalysis.
    Haines SJ; Walters BC
    Neurosurgery; 1994 Jan; 34(1):87-92. PubMed ID: 8121573
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Reduction in CSF shunt infection over a 10-year period associated with the application of concentrated topical antibiotic powder directly to surgical wounds prior to closure.
    Beckman JM; Amankwah EK; Tetreault LL; Tuite GF
    J Neurosurg Pediatr; 2015 Dec; 16(6):648-61. PubMed ID: 26382185
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Characteristics and treatment outcome of cerebrospinal fluid shunt-associated infections in adults: a retrospective analysis over an 11-year period.
    Conen A; Walti LN; Merlo A; Fluckiger U; Battegay M; Trampuz A
    Clin Infect Dis; 2008 Jul; 47(1):73-82. PubMed ID: 18484878
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effect of an intraoperative double-gloving strategy on the incidence of cerebrospinal fluid shunt infection.
    Tulipan N; Cleves MA
    J Neurosurg; 2006 Jan; 104(1 Suppl):5-8. PubMed ID: 16509473
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Shunt complications in children with myelomeningocele: effect of timing of shunt placement. Clinical article.
    Radmanesh F; Nejat F; El Khashab M; Ghodsi SM; Ardebili HE
    J Neurosurg Pediatr; 2009 Jun; 3(6):516-20. PubMed ID: 19485738
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Frequency of infections after shunting of hydrocephalus. An analysis of 884 shunts].
    Molke Borgbjerg B; Gjerris F; Albeck MJ; Børgesen SE
    Ugeskr Laeger; 1997 May; 159(19):2867-71. PubMed ID: 9190715
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Conservative management of patients with cerebrospinal fluid shunt infections.
    Brown EM; Edwards RJ; Pople IK
    Neurosurgery; 2006 Apr; 58(4):657-65; discussion 657-65. PubMed ID: 16575329
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Antibiotic-impregnated shunt catheters for the treatment of infantile hydrocephalus.
    Sciubba DM; Noggle JC; Carson BS; Jallo GI
    Pediatr Neurosurg; 2008; 44(2):91-6. PubMed ID: 18230921
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Treatment of cerebrospinal fluid shunting complications in a Nigerian neurosurgery programme. Case illustrations and review.
    Komolafe EO; Adeolu AA; Komolafe MA
    Pediatr Neurosurg; 2008; 44(1):36-42. PubMed ID: 18097189
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Shunt infection: is there a near-miss scenario?
    Thompson DN; Hartley JC; Hayward RD
    J Neurosurg; 2007 Jan; 106(1 Suppl):15-9. PubMed ID: 17233307
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Treatment of cerebrospinal fluid shunt infections in children using systemic and intraventricular antibiotic therapy in combination with externalization of the ventricular catheter: efficacy in 34 consecutively treated infections.
    Arnell K; Enblad P; Wester T; Sjölin J
    J Neurosurg; 2007 Sep; 107(3 Suppl):213-9. PubMed ID: 17918527
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Management of shunt infections: a multicenter pilot study.
    Kestle JR; Garton HJ; Whitehead WE; Drake JM; Kulkarni AV; Cochrane DD; Muszynski C; Walker ML
    J Neurosurg; 2006 Sep; 105(3 Suppl):177-81. PubMed ID: 16970229
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Complications associated with bacitracin powder in surgical wounds.
    Beckman JM; Amankwah EK; Tetreault LL; Perlman SA; Tuite GF
    J Neurosurg Pediatr; 2015 Dec; 16(6):719-25. PubMed ID: 26382180
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.